Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 20 record(s)

Req # A-2022-01918

Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2022

Req # A-2021-00107

Provide 2020, 2021 lessons learned and BMD's/incident reports on Darlington unit 2 refurbishing and associated costs/cost overruns. Provide expected obstacles, challenges to encounter to encounter in refurbishing Darlington unit 3, 1 and 4 , including assessing plans, vendors, financial and safety risks.

Organization: Canadian Nuclear Safety Commission

0 page(s)
January 2022

Req # A-2021-24151

All data source files used to produce the CompassRx 7th Edition Annual Public Drug Plan Expenditure Report, 2019/20, published November 2021 and available here:https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/compassrx-7th-edition.html and here:https://www.canada.ca/content/dam/pmprb-cepmb/documents/npduis/analytical-studies/compassrx-7th-edition/NPDUIS-CompassRx7th-2019-2020_en.pdf.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
January 2022

Req # A-2021-00057

A copy of the bathymetric maps of Marechal and Caribou lakes in La Mauricie National Park, Quebec

Organization: Parks Canada

0 page(s)
October 2021

Req # A-2021-00052

Provide a copy of the briefing note “Regan Dow v. Canadian Nuclear Safety Commission” It is dated 2021-06-30 Ref # 6596361.

Organization: Canadian Nuclear Safety Commission

0 page(s)
September 2021

Req # A-2021-00055

Provide the briefing note “Applying the Precautionary Principle in Canada Nuclear Safety Commission Decision-Making – February 26, 2020” It is dated 2021-05-06 Ref # 6241579.

Organization: Canadian Nuclear Safety Commission

0 page(s)
September 2021

Req # A-2020-00203

Please provide: 1) Copy [name withheld] Letter delivered on June 16, 2020, to the CNSC President. 2) Edoc Number of [name withheld], Lawyer, letter delivered, on June 16, 2020, 3) Copy of any email(s) sent to [name withheld], Lawyer by CNSC Staff.

Organization: Canadian Nuclear Safety Commission

0 page(s)
May 2021

Req # A 2019_0008

Records from the Canada Development Investment Corporation related to the Trans Mountain Pipeline and Pipeline Expansion projects. Specifically: A copy of the Credit Agreements(s) with Her Majesty in Right of Canada doing business as Export Development Canada on behalf of the Canada Account and the Trans Mountain Project Finance (TMP Finance). Include documentation related to the following facilities: Acquisition; Construction; NEB. Include an amortization schedule that demonstrate the planned repayment of interest and principal. Any currently available transaction records (dated January 2019 or later) reflecting draws against the credit lines for the three facilities. A copy of the Credit Agreement(s) between Trans Mountain Project Finance and Trans Mountain Corporation. Any agreements from funders other than the Canada Account/EDC that provide funds for the closing in May 2018. Include copies of any Credit or other agreements that detail terms and conditions, as well as related amortization schedules if applicable. Exclude: draft documents, duplicates, e-mails, media monitoring, French documents if they exist in an English format, portions of documents that have no relevancy to the subject of the request.

Organization: Canada Development Investment Corporation

0 page(s)
March 2021

Req # A 2019_0016

The Nov 2019 agenda that Stephen Swaffield received for the Nov 2019 meeting of the Board of Directors of Trans Mountain Corporation. Please include any attachments, appendices and minutes.

Organization: Canada Development Investment Corporation

0 page(s)
March 2021

Req # A 2019_0018

2019, 2020 records, either in-house or by consultants that describe the rise in the estimated Trans Mountain pipeline expansion costs, the difficulties posed in administering/facilitating this asset and construction expansion, as well as then the implications such cost rises and construction obstacles pose for selling this asset. Include summary of private sector groups interested in purchasing the asset and the steps/procedures in place or being developed to facilitate a sale. Include CDEV costs and future costs for administration/marketing of this asset, both in house via outside firms.

Organization: Canada Development Investment Corporation

0 page(s)
March 2021
Date modified: